Phase II study of VR647 for Asthma in children
Phase of Trial: Phase II
Latest Information Update: 21 Mar 2018
At a glance
- Drugs Budesonide (Primary)
- Indications Asthma
- Focus Therapeutic Use
- 21 Mar 2018 According to a Vectura media release, the study is expected to be complete in Q3 2018.
- 04 Jan 2018 According to a Vectura media release, first patient has been dosed in December 2017 and activities are expected to complete in mid-2018.
- 04 Jan 2018 Status changed from planning to recruiting according to Vectura media release.